| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/10/1993 | US5234936 Pyrimidocycloalkanes as a ii antagonists |
| 08/10/1993 | US5234930 Pyrazolopyridine compounds which have useful pharmaceutical utility |
| 08/10/1993 | US5234928 Quinazoline-3-alkanoic acid derivatives, their salts and their preparation processes |
| 08/10/1993 | US5234906 Hyperglycemic compositions |
| 08/10/1993 | CA1321282C Parathyroid hormone antagonists |
| 08/10/1993 | CA1321281C Humoral hypercalcemic factor antagonists |
| 08/10/1993 | CA1321198C Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate |
| 08/10/1993 | CA1321141C Biologically active agent from human breast cyst fluid |
| 08/06/1993 | WO1992012638A1 METHOD FOR DELIVERING DIRECT FEED MICROORGANISMS TO POULTRY $i(IN OVO) |
| 08/05/1993 | WO1993015198A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
| 08/05/1993 | WO1993015109A2 Parathyroid hormone fragments, their preparation and medicaments containing the same |
| 08/05/1993 | WO1993015106A1 Cyclic calcitonine derivatives and method for their production |
| 08/05/1993 | WO1993015080A1 Azabicyclo compounds as calcium channel antagonists |
| 08/05/1993 | WO1993015073A1 Azabricyclic compounds as calcium channel antagonists |
| 08/05/1993 | WO1993015058A1 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| 08/05/1993 | WO1993015052A1 Compounds as calcium channel antagonists |
| 08/05/1993 | WO1993014763A1 1α-HYDROXY-24-EPI-VITAMIN D¿4? |
| 08/05/1993 | DE4203040A1 Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel New parathyroid hormone fragment, containing their production and this drug |
| 08/05/1993 | CA2129120A1 1.alpha.-hydroxy-24-epi-vitamin d4 |
| 08/05/1993 | CA2128536A1 Azabicyclo compounds as calcium channel antagonists |
| 08/05/1993 | CA2126974A1 New parathormone fragments, their preparation and medicaments containing these |
| 08/05/1993 | CA2125877A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
| 08/04/1993 | EP0553777A2 Fast dissolving tablet and its production |
| 08/04/1993 | EP0553312A1 Synthetic calcitonin peptides |
| 08/04/1993 | EP0553263A1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
| 08/04/1993 | EP0553218A1 Indole derivatives |
| 08/04/1993 | EP0553156A1 Chromans and thiochromans with retinoid-like activity |
| 08/03/1993 | US5232946 Promoting weight gain and reduction of blood sugar and fat deposits in animals, feed efficiency |
| 08/03/1993 | US5232733 Alginates prevent precipitation of guar hydrogels during storage |
| 08/03/1993 | US5232696 Immobilizing phospholipase, contacting with blood to hydrolyze glycerophospholipid for rapid metabolism |
| 08/03/1993 | CA1320957C Pyridazinone derivatives |
| 08/03/1993 | CA1320907C Cell membrane proteins, compositions containing them and procedure for their preparation |
| 07/28/1993 | EP0552631A1 Alpha-aryl-alpha-hydroxy-beta-imidazolinylpropionamides |
| 07/28/1993 | EP0552256A1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 07/28/1993 | EP0552246A1 Therapeutically useful 2-aminotetralin derivatives |
| 07/28/1993 | EP0552142A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 07/28/1993 | CN1074680A Thiazolidine compound, preparing process thereof and its application in medicine |
| 07/28/1993 | CN1074679A Benzoquinonyl-containing thiazolidine compound, preparing process thereof and its application in medicine |
| 07/27/1993 | US5231090 Treatment for hypercholesterolemia |
| 07/27/1993 | CA1320727C Pharmaceutical compositions containing geminal diphosphonates |
| 07/27/1993 | CA1320723C Phenylacetic acid derivatives |
| 07/24/1993 | CA2087650A1 .alpha.-aryl-.alpha.-hydroxy-.beta.-imidazolinyl-propionamides |
| 07/22/1993 | WO1993014076A1 Piperazine derivatives as 5-ht receptors antagonists |
| 07/22/1993 | WO1993013799A1 Methods of terminating pregnancy |
| 07/22/1993 | WO1993013660A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 07/22/1993 | CA2128017A1 Methods of terminating pregnancy |
| 07/22/1993 | CA2125182A1 Piperazine derivatives as 5-ht receptors antagonists |
| 07/21/1993 | EP0552106A1 Peptide antagonists of bradykinin |
| 07/21/1993 | EP0551844A2 Bile acid sulfurated derivatives |
| 07/21/1993 | EP0420875B1 Fine-milled colestipol hydrochloride |
| 07/20/1993 | US5229390 Beverage |
| 07/20/1993 | US5229136 Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients |
| 07/20/1993 | CA1320447C Antidiabetic composition comprising isocarbacyclin derivative |
| 07/20/1993 | CA1320441C Use of growth hormone for nitrogen retention under hypocaloric conditions |
| 07/18/1993 | CA2087379A1 Pseudopeptidic derivatives having an antigonistic activity for bradykinine, process for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0550595A1 Methods |
| 07/14/1993 | EP0550574A1 Heterocyclic compounds |
| 07/14/1993 | EP0550482A1 Methods for inhibiting rejection of transplanted tissue |
| 07/14/1993 | EP0550444A1 Substituted naphthoxazines useful as dopaminergics |
| 07/14/1993 | EP0334889B1 Composition for treating obesity |
| 07/14/1993 | CN1074123A Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level |
| 07/13/1993 | US5227518 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis |
| 07/13/1993 | US5227479 Process for the preparation of nojirimycin and related compounds |
| 07/13/1993 | US5227371 Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations |
| 07/13/1993 | CA1320204C Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters |
| 07/13/1993 | CA1320201C 4,5,6-substituted-2-pyrimidinamines |
| 07/13/1993 | CA1320195C Adenosine derivatives |
| 07/08/1993 | WO1993013126A1 Peptide compounds having therapeutic activity |
| 07/08/1993 | WO1993013092A1 Imidazolidinedione derivatives |
| 07/08/1993 | WO1993013074A1 Substituted imidazole derivatives and their preparation and use |
| 07/08/1993 | WO1993012808A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | WO1993012798A1 Obesity inhibitor |
| 07/08/1993 | WO1993012793A1 A therapeutic process for the treatment of the pathologies of type ii diabetes |
| 07/08/1993 | WO1993012786A1 Indolinone derivatives |
| 07/08/1993 | WO1993012764A1 Composition to help stop smoking |
| 07/08/1993 | WO1993012139A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | WO1992017077A3 Fat substitute compositions having reduced laxative effects |
| 07/08/1993 | CA2126236A1 Peptide compounds having therapeutic activity |
| 07/08/1993 | CA2126212A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | CA2126108A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/07/1993 | EP0550337A1 Tissue protective tocopherol analogs |
| 07/07/1993 | EP0550292A1 Tissue protective tocopherol analogs |
| 07/07/1993 | EP0550060A1 Cholesterol regulating material, cholesterol or body weight regulating composition, food, food material, beverage, and use of cholesterol regulating material |
| 07/07/1993 | EP0549967A1 Polymers and oligomers of bile-acids, process for their production and their use as medicines |
| 07/07/1993 | EP0549804A1 Acat inhibitor |
| 07/07/1993 | EP0549660A1 Enhancement of glutathione levels with glutamine |
| 07/07/1993 | EP0549600A1 5-trifluoroacylamino-2-aryl oxazoles |
| 07/07/1993 | EP0412110B1 Novel vitamin d analogues |
| 07/06/1993 | US5225426 Thiazolidine-2,4-dione compound and method of treatment of diabetic complications |
| 07/06/1993 | US5225323 Human high-affinity neurotransmitter uptake system |
| 07/01/1993 | CA2086566A1 Inhibitor for absorption of digested and decomposed products of food and drink |
| 06/30/1993 | EP0549433A1 Use of N'-substituted N-phenylsulfonylureas in the treatment of hypertension in insulin-resistant patients |
| 06/30/1993 | EP0549366A1 Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses |
| 06/30/1993 | EP0549365A1 Thiazolidine compounds, their preparation and their therapeutic uses |
| 06/30/1993 | EP0549318A2 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same |
| 06/30/1993 | EP0548794A2 Polyaspartamide derivative as adsorbent for bile acids, polyaspartamide loaded with bile acids and preparation and use as a drug |
| 06/30/1993 | EP0548793A2 Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor |
| 06/30/1993 | EP0548227A1 Compounds |
| 06/30/1993 | EP0542864A4 Treatment for hypercholesterolemia |
| 06/30/1993 | CN1073684A Polypeptide analogues having growth hormone releasing activity |